Rita_Alloway

Dr. Rita R. Alloway PharmD, FCCP

University of Cincinnati College of Medicine

Rita R. Alloway, PharmD, FCCP received her Doctor of Pharmacy degree from the University of Tennessee College of Pharmacy in 1988. Currently she is Research Professor in the College of Medicine at the University of Cincinnati and Director of Transplant Clinical Research. Dr. Alloway’s practice areas include kidney, liver and pancreas solid organ transplantation. Her individual research efforts focus on the goal of individualizing immunosuppressive regimens in the transplant patient. She currently directs several industry sponsored and investigator initiated investigational drug trials of which she serves as both principal and collaborating investigator.

She is an elected member of the American College of Clinical Pharmacy (ACCP) and American Society of Transplantation (AST). In 2014, she was awarded the Russell R. Miller Award presented in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy. 
 
 
 
Biosketch
Rita R. Alloway, PharmD, FCCP received her Doctor of Pharmacy degree from the University of Tennessee College of Pharmacy in 1988. She completed an ASHP-accredited Pharmacy Practice Residency at the Veteran's Administration Medical Center, Memphis in 1989. Following completion of post-doctoral training, Dr. Alloway obtained a position as a clinical pharmacist at UT Bowld Hospital where she served ten years as Director of Clinical Pharmacy Services. In 1994, she received Board Certification in Pharmacotherapy. From 1997-2000, she was appointed as Director of the Transplant Clinical Pharmacotherapy Research Institute. Currently she is Research Professor in the College of Medicine at the University of Cincinnati and Director of Transplant Clinical Research. 
 
While at the University of Tennessee, Memphis, Dr. Alloway began a pharmacy specialty residency in solid organ transplant in 1994. In 1999, she initiated a fellowship in solid organ transplant with a focus on clinical research. These program were continued at the University of Cincinnati where to date she has trained over 30 pharmacy residents and fellows in solid organ transplantation. 
 
Dr. Alloway’s practice areas include kidney, liver and pancreas solid organ transplantation. Her work in transplantation pharmacotherapy has generated numerous publications and invited lectures to present specific research results and overviews of transplant immunosuppression. Dr. Alloway’s individual research efforts focus on the goal of individualizing immunosuppressive regimens in the transplant patient. She currently directs several industry sponsored and investigator initiated investigational drug trials of which she serves as both principal and collaborating investigator. Currently she has serves PI on a U01 and FDA grant studying the impact of generic tacrolimus in transplant recipients. She also serves as a co-investigator and director of the coordinating center for a 315 patient, 8-center investigator initiated study focusing on the impact of a corticosteroid free/calcineurin free immunosuppressive regimen in renal transplant recipients.
 
She is an elected member of the American College of Clinical Pharmacy (ACCP) and American Society of Transplantation (AST). Currently she is a member of the Immunology/Transplant Practice Research Network of the ACCP.  Dr. Alloway served as the president of the MidSouth College of Clinical Pharmacy, and ACCP Transplant/Immunology PRN Chair. 
 
As a member of the AST, she currently serves as Councilor at Large on the AST Board, a past Chair of the Transplant Pharmacy Community of Practice, and Public Policy Committee. Her long-standing mentoring and training efforts in transplantation were recognized by AST when she was awarded the 2013 AST Mentoring Award.
 
In 2014, she was awarded the Russell R. Miller Award presented in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy.  In 2007 she was elected as a Fellow of the American College of Clinical Pharmacy and recognized locally as a “Leading Woman of Cincinnati in Research and Technology”.


Appearances